changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
Certain BTG products may not be available within the chosen location and indications may differ from your country's approved use.
For Medical questions regarding any BTG products, please contact firstname.lastname@example.org
Embolic beads for the embolisation of arteriovenous malformations and hypervascular tumours including uterine fibroids
The only spherical embolic agent comprised of PVA hydrogel cross-linked with acrylic polymer
The role of interventional radiologists in treating liver cancer is well established and we are proud of the products we offer that target cancer while decreasing toxicity to healthy liver and minimising side effects.1,8,9
For 10 years, we have been devoted to supporting clinicians in improving the standard of care with innovative medical technologies for millions of emphysema sufferers worldwide.
BTG helps interventional vascular teams solve problems with patients’ blood transport systems through evidence-based innovations that treat smarter and achieve more.
EKOS™ is setting the standard for PE treatment safety and efficacy, again. With the EKOS™ treatment’s successful very-low dose and short duration regimens in the OPTALYSE PE trial and favorable long term data results point to a paradigm-changing approach for PE treatment.
Synergy: A Multidisciplanary Approach to...
A Retrospective Study of Medicare claim ...
NHS England expands loco-regional treatm...
Australian Patient Treated With DC Bead ...